RETN and neoplasm: Moreover, animal models of lung cancer have shown that mice treated with anti-resistin antibodies exhibited reduced rates of lung cancer development and metastasis (181), further proving that resistin, by modulating inflammatory responses in the tumor microenvironment, indirectly facilitates lung cancer bone metastasis.